Fibrin Sealants in Dura Sealing: A Systematic Literature Review

Abstract

BackgroundFibrin sealants are widely used in neurosurgery to seal the suture line, provide watertight closure, and prevent cerebrospinal fluid leaks. The aim of this systematic review is to summarize the current efficacy and safety literature of fibrin sealants in dura sealing and the prevention/treatment of cerebrospinal fluid leaks.MethodsA comprehensive electronic literature search was run in the following databases: Cochrane Database of Systematic Reviews, Cochrane Central Resister of Controlled Trials, clinicaltrials.gov, MEDLINE/PubMed, and EMBASE. Titles and abstracts of potential articles of interest were reviewed independently by 3 of the authors.ResultsA total of 1006 database records and additional records were identified. After screening for duplicates and relevance, a total of 78 articles were assessed by the investigators for eligibility. Thirty-eight were excluded and the full-text of 40 articles were included in the qualitative synthesis. Seven of these included only safety data and were included in the safety assessment. The remaining 33 articles included findings from 32 studies that enrolled a total of 2935 patients who were exposed to fibrin sealant. Among these 33 studies there were only 3 randomized controlled trials, with the remaining being prospective cohort analysis, case controlled studies, prospective or retrospective case series. One randomized controlled trial, with 89 patients exposed to fibrin sealant, found a greater rate of intraoperative watertight dura closure in the fibrin sealant group than the control group (92.1% versus 38.0%, p<0.001); however, post-operative cerebrospinal fluid leakage occurred in more fibrin sealant than control patients (6.7% versus 2.0%, p>0.05). Other clinical trials evaluated the effect of fibrin sealant in the postoperative prevention of cerebrospinal fluid leaks. These were generally lower level evidence studies (ie, not prospective, randomized, controlled trials) that were not designed or powered to demonstrate a significant advantage to fibrin sealant use. Two small case series studies evaluated the effect of fibrin sealants in persistent cerebrospinal fluid leak treatment, but did not establish firm efficacy conclusions. Specific adverse reports where fibrin sealants were used for dura sealing were limited, with only 8 cases reported in neurosurgical procedures since 1987 and most reporting only a speculative relationship/association with fibrin sealant exposure.ConclusionsA major finding of this systematic literature review is that there is a paucity of randomized studies that have evaluated the effectiveness and safety of fibrin sealants in providing intraoperative watertight dura closure and post-operative cerebrospinal fluid leakage. Among the limited studies available, evidence from a single randomized, controlled trial indicates that fibrin sealants provide a higher rate of intraoperative watertight closure of the dura suture line than control, albeit with a higher rate of postoperative cerebrospinal fluid leakage. Evidence from non-random...

Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy

“…However, matrix‐bound adhesives have been investigated for their sealing properties in non‐haemostatic indications. Adhesives have shown beneficial results in sealing off air leakage of the lung, reducing the incidence of lymphatic leaks after urological and gynaecological interventions, and cerebrospinal fluid leaks after neurosurgery.…”

Hemostasis mechanism and applications of N-alkylated chitosan sponge

“…The largest effort has come from the United States Army in their evaluation of sprayable fibrin foams for use in truncal bleeding . However, results with the fibrin sprays have been equivocal, and fibrin use in the field is limited due to its cost, storage requirements, and preparation before application . Other products, such as thrombin‐based hemostatic agents, lyophilized platelets, conjugated red blood cells (RBCs), and fibrinogen‐coated albumin microparticles also have limitations for practical applications …”

Electric- Field-Modified In Situ Precise Deposition of Electrospun Medical Glue Fibers on the Liver for Rapid Hemostasis

“…It uses two mercury-free alkaline AAA batteries (diameter 10 mm, height 44 mm; LR03, Fujian Nanping, Nanfu Battery, China) as power supply with a high-voltage converter and gets rid of the limitation of urban electricity supply that greatly develops the portable use in outdoors. Importantly, significantly different from our recent reported e-spinning device [ 11 ], a metallic cone with tunable size is equipped at the spinning needle. The introduction of the metallic cone would change original electromagnetic field distributions and affect the e-spinning process.…”

“…Similarly, thermal methods can damage the local tissues and may make it abnormal from normal tissue which cannot be distinguished easily [ 10 ]. Moreover, fibrin sealants widely used for hemostasis can easily lead to adverse human immune response, and they also have disadvantages such as short shelf life, vulnerable to microbial intrusion, and high price [ 11 ]. In contrast, e-spinning technology shows excellent potential in hemostasis for its special features such as using less dosage and coating on wound sites even with irregular surfaces [ 12 , 13 ].…”